223 related articles for article (PubMed ID: 16774544)
1. The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients.
Melum E; Karlsen TH; Broomé U; Thorsby E; Schrumpf E; Boberg KM; Lie BA
Tissue Antigens; 2006 Jul; 68(1):78-81. PubMed ID: 16774544
[TBL] [Abstract][Full Text] [Related]
2. CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis.
Eri R; Jonsson JR; Pandeya N; Purdie DM; Clouston AD; Martin N; Duffy D; Powell EE; Fawcett J; Florin TH; Radford-Smith GL
Genes Immun; 2004 Sep; 5(6):444-50. PubMed ID: 15215889
[TBL] [Abstract][Full Text] [Related]
3. The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms.
Sandford B; Bown M; London N; Sayers R
Int J Immunogenet; 2009 Aug; 36(4):199-205. PubMed ID: 19476483
[TBL] [Abstract][Full Text] [Related]
4. Genetic variations in CC chemokine receptors and hypertension.
Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
[TBL] [Abstract][Full Text] [Related]
5. The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer's disease.
Combarros O; Infante J; Llorca J; Peña N; Fernández-Viadero C; Berciano J
Neurosci Lett; 2004 Aug; 366(3):312-4. PubMed ID: 15288441
[TBL] [Abstract][Full Text] [Related]
6. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
[TBL] [Abstract][Full Text] [Related]
7. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
[TBL] [Abstract][Full Text] [Related]
8. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.
Kantarci OH; Morales Y; Ziemer PA; Hebrink DD; Mahad DJ; Atkinson EJ; Achenbach SJ; De Andrade M; Mack M; Ransohoff RM; Lassmann H; Bruck W; Weinshenker BG; Lucchinetti CF
J Neuroimmunol; 2005 Dec; 169(1-2):137-43. PubMed ID: 16182378
[TBL] [Abstract][Full Text] [Related]
9. CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility.
Srivastava A; Pandey SN; Choudhuri G; Mittal B
Scand J Immunol; 2008 May; 67(5):516-22. PubMed ID: 18405329
[TBL] [Abstract][Full Text] [Related]
10. CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitis.
Henckaerts L; Fevery J; Van Steenbergen W; Verslype C; Yap P; Nevens F; Roskams T; Libbrecht L; Rutgeerts P; Vermeire S
Inflamm Bowel Dis; 2006 Apr; 12(4):272-7. PubMed ID: 16633049
[TBL] [Abstract][Full Text] [Related]
11. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
[TBL] [Abstract][Full Text] [Related]
12. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5.
Gómez-Reino JJ; Pablos JL; Carreira PE; Santiago B; Serrano L; Vicario JL; Balsa A; Figueroa M; de Juan MD
Arthritis Rheum; 1999 May; 42(5):989-92. PubMed ID: 10323455
[TBL] [Abstract][Full Text] [Related]
13. The combination of primary sclerosing cholangitis and CCR5-Δ32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation.
op den Dries S; Buis CI; Adelmeijer J; Van der Jagt EJ; Haagsma EB; Lisman T; Porte RJ
Liver Int; 2011 Sep; 31(8):1102-9. PubMed ID: 21134114
[TBL] [Abstract][Full Text] [Related]
14. CC chemokine receptor 5 polymorphism in rheumatoid arthritis.
Garred P; Madsen HO; Petersen J; Marquart H; Hansen TM; Freiesleben Sørensen S; Volck B; Svejgaard A; Andersen V
J Rheumatol; 1998 Aug; 25(8):1462-5. PubMed ID: 9712084
[TBL] [Abstract][Full Text] [Related]
15. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.
Ioannidis JP; Contopoulos-Ioannidis DG; Rosenberg PS; Goedert JJ; De Rossi A; Espanol T; Frenkel L; Mayaux MJ; Newell ML; Pahwa SG; Rousseau C; Scarlatti G; Sei S; Sen L; O'Brien TR;
AIDS; 2003 Jul; 17(11):1631-8. PubMed ID: 12853745
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis.
Brajão de Oliveira K; Reiche EM; Kaminami Morimoto H; Pelegrinelli Fungaro MH; Estevão D; Pontello R; Franco Nasser T; Watanabe MA
J Cutan Pathol; 2007 Jan; 34(1):27-32. PubMed ID: 17214851
[TBL] [Abstract][Full Text] [Related]
17. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.
Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S
Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752
[TBL] [Abstract][Full Text] [Related]
19. Association of chemokines receptor (CCR5 Delta32) in idiopathic recurrent miscarriages among north Indians.
Parveen F; Tripathi G; Singh B; Agrawal S
Arch Gynecol Obstet; 2009 Aug; 280(2):229-34. PubMed ID: 19116725
[TBL] [Abstract][Full Text] [Related]
20. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
Salem AH; Batzer MA
Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]